| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | A A Hanke | |
| C Joch | |||
| K Görlinger | |||
| P2860 | cites work | Beriplex P/N reverses severe warfarin-induced overanticoagulation immediately and completely in patients presenting with major bleeding | Q43885621 |
| Rapid reversal of oral anticoagulation with warfarin by a prothrombin complex concentrate (Beriplex): efficacy and safety in 42 patients | Q43889363 | ||
| Correction of INR by prothrombin complex concentrate and vitamin K in patients with warfarin related hemorrhagic complication | Q44314655 | ||
| Thromboembolic safety and efficacy of prothrombin complex concentrates in the emergency reversal of warfarin coagulopathy | Q44779656 | ||
| Efficacy and safety of a prothrombin complex concentrate with two virus-inactivation steps in patients with severe liver damage | Q45729423 | ||
| Assessing emerging infectious threats to blood safety for the blood disorders community | Q45857944 | ||
| Identification of prothrombin as a major thrombogenic agent in prothrombin complex concentrates | Q45876129 | ||
| The dangers of prothrombin complex concentrate administration after heart surgery | Q46441752 | ||
| First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study | Q46939952 | ||
| Emergency reversal of anticoagulation: the real use of prothrombin complex concentrates: a prospective multicenter two year French study from 2006 to 2008. | Q46959051 | ||
| Efficacy and safety of a prothrombin complex concentrate (Octaplex) for rapid reversal of oral anticoagulation | Q47266490 | ||
| The increasing incidence of anticoagulant-associated intracerebral hemorrhage | Q48315722 | ||
| Use of rotation thromboelastometry (ROTEM) to achieve successful treatment of polytrauma with fibrinogen concentrate and prothrombin complex concentrate | Q48392324 | ||
| Prothrombin complex concentrate (Octaplex) in patients requiring immediate reversal of oral anticoagulation. | Q52926693 | ||
| Successful emergency reversal of phenprocoumon anticoagulation with prothrombin complex concentrate: a prospective clinical study. | Q53229967 | ||
| Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrat | Q53539960 | ||
| Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy. | Q53973073 | ||
| Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists | Q59541570 | ||
| Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy | Q71264573 | ||
| Thromboembolic complications associated with the use of prothrombin complex and factor IX concentrates | Q77366926 | ||
| Ultra-rapid management of oral anticoagulant therapy-related surgical intracranial hemorrhage | Q79680727 | ||
| Perioperative myocardial infarction in a patient receiving low-dose prothrombin complex concentrates | Q79828524 | ||
| The headache over warfarin in British neurosurgical intensive care units: a national survey of current practice | Q80559413 | ||
| Individualized dosing regimen for prothrombin complex concentrate more effective than standard treatment in the reversal of oral anticoagulant therapy: an open, prospective randomized controlled trial | Q81257209 | ||
| Pharmacokinetics of Beriplex P/N prothrombin complex concentrate in healthy volunteers | Q81445945 | ||
| Biochemical comparison of seven commercially available prothrombin complex concentrates | Q81762781 | ||
| Observational study of fibrinogen concentrate in massive hemorrhage: evaluation of a multicenter register | Q82180743 | ||
| Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients | Q84853003 | ||
| Prothrombin complex concentrate (Beriplex P/N) in severe bleeding: experience in a large tertiary hospital | Q21195016 | ||
| Warfarin reversal | Q24672566 | ||
| Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy | Q28213401 | ||
| Antithrombotic therapy in valvular heart disease--native and prosthetic: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy | Q28213413 | ||
| Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial | Q28265484 | ||
| Urgent reversal of warfarin with prothrombin complex concentrate: where are the evidence-based data? | Q31040247 | ||
| The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy | Q31114479 | ||
| Coagulopathy in liver disease | Q33378419 | ||
| Prothrombin complex concentrate in surgical patients: retrospective evaluation of vitamin K antagonist reversal and treatment of severe bleeding | Q33612839 | ||
| Thrombogenicity of prothrombin complex concentrates | Q33739978 | ||
| Quality of anticoagulation management among patients with atrial fibrillation: results of a review of medical records from 2 communities. | Q33890031 | ||
| Management of bleeding following major trauma: an updated European guideline | Q33919178 | ||
| Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate | Q33919203 | ||
| The incidence of bleeding complications associated with warfarin treatment in general practice in the United Kingdom | Q34223484 | ||
| Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines | Q34252907 | ||
| The management of coumarin-induced over-anticoagulation Annotation | Q34351118 | ||
| Guidelines on oral anticoagulation (warfarin): third edition--2005 update | Q34484090 | ||
| Risk of major hemorrhage for outpatients treated with warfarin | Q34751905 | ||
| Clinical review: Prothrombin complex concentrates--evaluation of safety and thrombogenicity | Q35567088 | ||
| Hemorrhagic complications of anticoagulant treatment: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy | Q35895164 | ||
| Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy | Q35895168 | ||
| Thromboelastometry Based Early Goal-Directed Coagulation Management Reduces Blood Transfusion Requirements, Adverse Events, and Costs in Acute Type A Aortic Dissection: A Pilot Study | Q35998338 | ||
| Death and disability from warfarin-associated intracranial and extracranial hemorrhages | Q36501858 | ||
| Anticoagulants and their reversal | Q36686342 | ||
| Role of prothrombin complex concentrates in reversing warfarin anticoagulation: a review of the literature | Q36923137 | ||
| Survival of heparins, oral anticoagulants, and aspirin after the year 2010. | Q37130337 | ||
| Prothrombin complex concentrates: a brief review | Q37185539 | ||
| Warfarin-reversal: results of a phase III study with pasteurised, nanofiltrated prothrombin complex concentrate | Q37189941 | ||
| The new oral anticoagulants | Q37625561 | ||
| Prothrombin complex concentrates for oral anticoagulant therapy-related intracranial hemorrhage: a review of the literature | Q37646452 | ||
| Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention | Q40844377 | ||
| Prothrombin complex concentrate for oral anticoagulant reversal in neurosurgical emergencies | Q42046164 | ||
| Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group | Q42287205 | ||
| Impact of infusion speed on the safety and effectiveness of prothrombin complex concentrate: a prospective clinical trial of emergency anticoagulation reversal | Q43269909 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prothrombin complex concentrate | Q2044524 |
| P1104 | number of pages | 9 | |
| P304 | page(s) | 764-772 | |
| P577 | publication date | 2013-01-18 | |
| P1433 | published in | British Journal of Anaesthesia | Q72466 |
| P1476 | title | Long-term safety and efficacy of a pasteurized nanofiltrated prothrombin complex concentrate (Beriplex P/N): a pharmacovigilance study | |
| P478 | volume | 110 |
| Q30458252 | A 2014 Update on Coagulation Management for Cardiopulmonary Bypass |
| Q60935823 | Association between viscoelastic tests-guided therapy with synthetic factor concentrates and allogenic blood transfusion in liver transplantation: a before-after study |
| Q38211682 | Coagulation management with factor concentrates in liver transplantation: a single-center experience. |
| Q38915584 | Effectiveness of prothrombin complex concentrate (PCC) in neonates and infants with bleeding or risk of bleeding: a systematic review and meta-analysis |
| Q88792311 | Efficacy and safety of a 4-factor prothrombin complex concentrate for rapid vitamin K antagonist reversal in Japanese patients presenting with major bleeding or requiring urgent surgical or invasive procedures: a prospective, open-label, single-arm |
| Q34485905 | Endogenous thrombin potential following hemostatic therapy with 4-factor prothrombin complex concentrate: a 7-day observational study of trauma patients |
| Q38197728 | Four factor prothrombin complex concentrate (human): review of the pharmacology and clinical application for vitamin K antagonist reversal |
| Q89943293 | Impaired platelet-dependent thrombin generation associated with thrombocytopenia is improved by prothrombin complex concentrates in vitro |
| Q90251395 | Korean clinical practice guideline for perioperative red blood cell transfusion from Korean Society of Anesthesiologists |
| Q33435884 | Monitoring and Treatment of Coagulation Disorders in End-Stage Liver Disease |
| Q54257622 | New oral anticoagulant drugs: real-world data. |
| Q40338659 | Pathogen safety of a pasteurized four-factor human prothrombin complex concentrate preparation using serial 20N virus filtration |
| Q38273787 | Practical management of major blood loss |
| Q38182963 | Prothrombin complex concentrate |
| Q53242381 | ROTEM monitoring of activated and non-activated prothrombin complex concentrate correction of dilutional coagulopathy. |
| Q48503140 | Retrospective Review of a Prothrombin Complex Concentrate (Beriplex P/N) for the Management of Perioperative Bleeding Unrelated to Oral Anticoagulation. |
| Q33421728 | Reversal of warfarin anticoagulation for urgent surgical procedures |
| Q26863536 | Role of prothrombin complex concentrate in perioperative coagulation therapy |
| Q37352419 | Safety of a Four-factor Prothrombin Complex Concentrate Versus Plasma for Vitamin K Antagonist Reversal: An Integrated Analysis of Two Phase IIIb Clinical Trials |
| Q64936119 | Safety of coagulation factor concentrates guided by ROTEM™-analyses in liver transplantation: results from 372 procedures. |
| Q92083460 | The role of evidence-based algorithms for rotational thromboelastometry-guided bleeding management |
| Q38600324 | Theoretical Modeling of Coagulation Management With Therapeutic Plasma or Prothrombin Complex Concentrate. |
Search more.